Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis

被引:112
作者
Farrell, Amy S. [1 ]
Pelz, Carl [1 ,3 ]
Wang, Xiaoyan [1 ]
Daniel, Colin J. [1 ]
Wang, Zhiping [1 ]
Su, Yulong [1 ]
Janghorban, Mahnaz [1 ]
Zhang, Xiaoli [1 ]
Morgan, Charlie [2 ]
Impey, Soren [3 ]
Sears, Rosalie C. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[2] Univ Calif San Francisco, Dept Chem & Chem Biol, San Francisco, CA 94143 USA
[3] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA
关键词
PROLYL-ISOMERASE PIN1; UBIQUITIN-MEDIATED PROTEOLYSIS; BREAST-CANCER; PROTEIN STABILITY; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; EPITHELIAL-CELLS; GENOMIC TARGETS; RNA-POLYMERASE; MAMMARY-GLAND;
D O I
10.1128/MCB.01455-12
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Myc oncoprotein is considered a master regulator of gene transcription by virtue of its ability to modulate the expression of a large percentage of all genes. However, mechanisms that direct Myc's recruitment to DNA and target gene selection to elicit specific cellular functions have not been well elucidated. Here, we report that the Pin1 prolyl isomerase enhances recruitment of serine 62-phosphorylated Myc and its coactivators to select promoters during gene activation, followed by promoting Myc's release associated with its degradation. This facilitates Myc's activation of genes involved in cell growth and metabolism, resulting in enhanced proproliferative activity, even while controlling Myc levels. In cancer cells with impaired Myc degradation, Pin1 still enhances Myc DNA binding, although it no longer facilitates Myc degradation. Thus, we find that Pin1 and Myc are cooverexpressed in cancer, and this drives a gene expression pattern that we show is enriched in poor-outcome breast cancer subtypes. This study provides new insight into mechanisms regulating Myc DNA binding and oncogenic activity, it reveals a novel role for Pin1 in the regulation of transcription factors, and it elucidates a mechanism that can contribute to oncogenic cooperation between Pin1 and Myc.
引用
收藏
页码:2930 / 2949
页数:20
相关论文
共 87 条
[1]   Bootstrap tests for distributional treatment effects in instrumental variable models [J].
Abadie, A .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2002, 97 (457) :284-292
[2]   Proteomic profiling of Myc-associated proteins [J].
Agrawal, Pooja ;
Yu, Kebing ;
Salomon, Arthur R. ;
Sedivy, John M. .
CELL CYCLE, 2010, 9 (24) :4908-4921
[4]   Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis [J].
Andrechek, ER ;
Hardy, WR ;
Siegel, PM ;
Rudnicki, MA ;
Cardiff, RD ;
Muller, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3444-3449
[5]   Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels [J].
Arabi, A ;
Rustum, C ;
Hallberg, E ;
Wright, APH .
JOURNAL OF CELL SCIENCE, 2003, 116 (09) :1707-1717
[6]   Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation [J].
Arnold, HK ;
Sears, RC .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (07) :2832-2844
[7]   The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc [J].
Arnold, Hugh K. ;
Zhang, Xiaoli ;
Daniel, Colin J. ;
Tibbitts, Deanne ;
Escamilla-Powers, Julie ;
Farrell, Amy ;
Tokarz, Sara ;
Morgan, Charlie ;
Sears, Rosalie C. .
EMBO JOURNAL, 2009, 28 (05) :500-512
[8]  
Ayala G, 2003, CANCER RES, V63, P6244
[9]   Getting at MYC through RAS [J].
Bachireddy, P ;
Bendapudi, PK ;
Felsher, DW .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4278-4281
[10]   Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency [J].
Barna, Maria ;
Pusic, Aya ;
Zollo, Ornella ;
Costa, Maria ;
Kondrashov, Nadya ;
Rego, Eduardo ;
Rao, Pulivarthi H. ;
Ruggero, Davide .
NATURE, 2008, 456 (7224) :971-U79